Curanex Pharmaceuticals Inc (CURX)
NASDAQ: CURX · Real-Time Price · USD
0.2109
-0.0119 (-5.34%)
At close: Jul 13, 2026
Curanex Pharmaceuticals Market Cap
Curanex Pharmaceuticals has a market cap or net worth of $5.98 million as of July 13, 2026.
Market Cap
5.98M
Enterprise Value
2.61M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since the IPO on August 26, 2025, Curanex Pharmaceuticals's market cap has decreased from $111.00M to $5.98M, a decrease of -94.61%. That is a compound annual growth rate of -96.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 5.98M | -36.15% |
| Dec 31, 2025 | 9.37M | -91.56% |
| Aug 26, 2025 | 111.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 6.54M |
| Acurx Pharmaceuticals | 6.45M |
| Aptorum Group | 6.37M |
| Addex Therapeutics | 6.36M |
| BioAtla | 6.34M |
| Pulmatrix | 6.28M |
| Xenetic Biosciences | 6.27M |
| AIM ImmunoTech | 6.25M |